Optimal Timing for Assessment of Tumor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer: Do All Patients Benefit From Waiting Longer Than 6 Weeks?

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics